Buy CABGOLIN 0.5MG Cabergoline Tablets USP Online

Description: ABGOLIN 0.5MG Cabergoline Tablets USP are a medication used primarily to treat hyperprolactinemia (high levels of prolactin hormone) and related disorders. Each tablet contains 0.5 mg of cabergoline, a dopamine receptor agonist that works by reducing the secretion of prolactin from the pituitary gland.

Indications:

• Treatment of hyperprolactinemia and its symptoms, such as infertility, irregular menstrual periods, and breast milk production in non-breastfeeding women.
• Management of prolactin-secreting adenomas (tumors of the pituitary gland).

Dosage and Administration: The usual dosage for ABGOLIN 0.5MG Cabergoline Tablets USP is determined by a healthcare provider based on the patient’s condition and response to treatment. It is typically taken orally once or twice a week. Dosage adjustments may be necessary based on individual patient needs and tolerability.

Contraindications:

• Hypersensitivity to cabergoline or any component of the formulation.
• Uncontrolled hypertension or significant cardiovascular disease.
• History of fibrotic disorders or cardiac valvulopathy.

Warnings and Precautions:

• Regular monitoring of cardiac function, including echocardiography, is recommended due to the potential risk of cardiac valvulopathy.
• Use caution in patients with renal impairment as dosage adjustments may be necessary.
• Avoid use during pregnancy and lactation unless clearly indicated and under medical supervision.

Adverse Reactions: Common adverse reactions may include nausea, headache, dizziness, and fatigue. Rare but serious adverse effects include psychiatric disorders, including hallucinations and psychotic disorders, and rare cases of fibrotic complications.

Storage: Store ABGOLIN 0.5MG Cabergoline Tablets USP in a cool, dry place away from direct sunlight. Keep out of reach of children.

Disclaimer: This product description is for informational purposes only and should not replace professional medical advice. Always consult a healthcare provider for diagnosis and treatment recommendations.